why choose us

First received: October 22, 2024

Clinical Trial: Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Multiple Sclerosis

Study Type: OBSERVATIONAL


Official Title: Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation (MS-PEKOS)

Brief Summary: The study aims to compare the experiences, including injection-related reactions (IRRs) of patients newly receiving ofatumumab to those starting to receive ocrelizumab SC formulation

Read more